Rare diseases
Investigational molecules
Locations
706 conditions with trials, the busiest first
3 926 trials across Europe, recruiting first
Study on the Safety and Tolerability of OsteoDex for Patients with Relapsed or Refractory Multiple Myeloma
SwedenStudy on Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed High-Risk Multiple Myeloma Patients
GermanyStudy of Copanlisib with Rituximab and CHOP for Untreated Diffuse Large B-Cell Lymphoma in Patients Aged 18-80
GermanyStudy on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination
BelgiumStudy on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy
BelgiumStudy on MB-CART19.1 for Patients with Relapsed or Refractory CD19 Positive B Cell Malignancies
GermanyStudy on Ponatinib and Chemotherapy for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
ItalyStudy on the Effectiveness of Atezolizumab, Carboplatin, and Nab-Paclitaxel in Patients with Resectable Non-Small Cell Lung Cancer
GermanyStudy on Enzalutamide for Patients with Localized Prostate Cancer Undergoing Robotic-Assisted Surgery
SpainStudy of Pembrolizumab with Lenvatinib after Chemoradiation Treatment in Patients with Locally Advanced Head and Neck Cancer who are PD-L1 Positive
GermanyStudy on the Effects of IO102 Hydrochloride and IO103 Acetate for Patients with Head and Neck Cancer
BelgiumStudy of emapalumab in children and adults with Macrophage Activation Syndrome (MAS) occurring in Still's Disease or Systemic Lupus Erythematosus
CzechiaThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
